Judah Frommer
Stock Analyst at Morgan Stanley
(1.01)
# 3,593
Out of 4,402 analysts
450
Total ratings
50.5%
Success rate
-1.1%
Average return
Main Sectors:
Stocks Rated by Judah Frommer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KYMR Kymera Therapeutics | Maintained: Buy | $119 | $82.96 | +43.44% | 10 | Jun 9, 2026 | |
| INCY Incyte | Maintained: Hold | $102 → $103 | $107.83 | -4.48% | 10 | Jun 8, 2026 | |
| AVLN Avalyn Pharma | Maintained: Buy | $53 | $28.07 | +88.81% | 2 | Jun 3, 2026 | |
| ABVX ABIVAX Société Anonyme | Rated: Buy | $145 → $132 | $100.87 | +30.86% | 6 | Jun 2, 2026 | |
| PROK ProKidney | Rated: Hold | $3 | $1.66 | +80.72% | 14 | May 18, 2026 | |
| AGMB AgomAb Therapeutics NV | Maintained: Buy | $28 → $11 | $9.88 | +6.78% | 4 | May 18, 2026 | |
| RGNX REGENXBIO | Rated: Buy | $17 → $16 | $6.28 | +154.78% | 19 | May 15, 2026 | |
| CMPS COMPASS Pathways | Rated: Buy | $16 → $17 | $11.41 | +48.99% | 4 | May 14, 2026 | |
| ZBIO Zenas BioPharma | Maintained: Hold | $21 → $22 | $17.76 | +23.87% | 11 | May 14, 2026 | |
| KLRS Kalaris Therapeutics | Maintained: Buy | $14 | $4.35 | +221.84% | 2 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $37 | $21.28 | +73.87% | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $55 | $20.69 | +165.83% | 6 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $92 → $94 | $74.71 | +25.82% | 25 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $33 | $25.24 | +30.74% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $34 | $24.59 | +38.27% | 6 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.64 | - | 8 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $20 | $13.46 | +48.59% | 5 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $8.10 | +146.91% | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.84 | - | 12 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $22 | $28.90 | -23.88% | 50 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $191 → $201 | $136.85 | +46.88% | 2 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 → $44 | $29.96 | +46.86% | 8 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $141 → $139 | $15.00 | n/a | 17 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $138 | $0.0002 | n/a | 9 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $5.71 | n/a | 8 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $0.466 | n/a | 8 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.80 | n/a | 4 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $29.36 | n/a | 7 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $22 | $30.24 | n/a | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $7 | $8.16 | n/a | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $13 | $2.37 | n/a | 4 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $11 → $8 | $3.55 | n/a | 9 | Mar 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $6 → $7 | $3.15 | n/a | 10 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $55 | $26.82 | n/a | 6 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $46 | $96.72 | n/a | 3 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $3.5 | $0.947 | n/a | 1 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $24 | $91.23 | n/a | 7 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $26 | $88.12 | n/a | 10 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $15.39 | n/a | 2 | Jul 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $90 → $95 | $83.65 | n/a | 10 | Jul 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $328 | $975.69 | n/a | 6 | Jul 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $35 | $64.12 | n/a | 28 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $125 → $116 | $201.97 | n/a | 9 | Jun 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €22.00 → €24.00 | $36.26 | n/a | 3 | Jun 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $98 → $107 | $114.89 | n/a | 19 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $154 → $178 | $114.34 | n/a | 10 | May 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 → $38 | $90.93 | n/a | 4 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $67 → $63 | $79.64 | n/a | 17 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 | $104.06 | n/a | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $19.06 | n/a | 1 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $41.91 | n/a | 1 | Mar 6, 2019 |
Kymera Therapeutics
Jun 9, 2026
Maintained: Buy
Price Target: $119
Current: $82.96
Upside: +43.44%
Incyte
Jun 8, 2026
Maintained: Hold
Price Target: $102 → $103
Current: $107.83
Upside: -4.48%
Avalyn Pharma
Jun 3, 2026
Maintained: Buy
Price Target: $53
Current: $28.07
Upside: +88.81%
ABIVAX Société Anonyme
Jun 2, 2026
Rated: Buy
Price Target: $145 → $132
Current: $100.87
Upside: +30.86%
ProKidney
May 18, 2026
Rated: Hold
Price Target: $3
Current: $1.66
Upside: +80.72%
AgomAb Therapeutics NV
May 18, 2026
Maintained: Buy
Price Target: $28 → $11
Current: $9.88
Upside: +6.78%
REGENXBIO
May 15, 2026
Rated: Buy
Price Target: $17 → $16
Current: $6.28
Upside: +154.78%
COMPASS Pathways
May 14, 2026
Rated: Buy
Price Target: $16 → $17
Current: $11.41
Upside: +48.99%
Zenas BioPharma
May 14, 2026
Maintained: Hold
Price Target: $21 → $22
Current: $17.76
Upside: +23.87%
Kalaris Therapeutics
May 13, 2026
Maintained: Buy
Price Target: $14
Current: $4.35
Upside: +221.84%
May 12, 2026
Rated: Buy
Price Target: $36 → $37
Current: $21.28
Upside: +73.87%
May 11, 2026
Maintained: Buy
Price Target: $54 → $55
Current: $20.69
Upside: +165.83%
May 8, 2026
Maintained: Buy
Price Target: $92 → $94
Current: $74.71
Upside: +25.82%
May 8, 2026
Maintained: Hold
Price Target: $34 → $33
Current: $25.24
Upside: +30.74%
May 7, 2026
Maintained: Buy
Price Target: $35 → $34
Current: $24.59
Upside: +38.27%
May 7, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.64
Upside: -
May 5, 2026
Rated: Buy
Price Target: $18 → $20
Current: $13.46
Upside: +48.59%
Mar 26, 2026
Rated: Buy
Price Target: $20
Current: $8.10
Upside: +146.91%
Mar 18, 2026
Maintained: Hold
Price Target: n/a
Current: $8.84
Upside: -
Mar 16, 2026
Maintained: Sell
Price Target: $22
Current: $28.90
Upside: -23.88%
Mar 3, 2026
Maintained: Buy
Price Target: $191 → $201
Current: $136.85
Upside: +46.88%
Feb 26, 2026
Maintained: Buy
Price Target: $43 → $44
Current: $29.96
Upside: +46.86%
Aug 3, 2023
Maintained: Hold
Price Target: $141 → $139
Current: $15.00
Upside: n/a
Jun 5, 2023
Maintained: Buy
Price Target: $138
Current: $0.0002
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $13
Current: $5.71
Upside: n/a
May 15, 2023
Reiterated: Buy
Price Target: $40
Current: $0.466
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $9
Current: $3.80
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $28
Current: $29.36
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $21 → $22
Current: $30.24
Upside: n/a
Mar 31, 2023
Maintained: Buy
Price Target: $8 → $7
Current: $8.16
Upside: n/a
Mar 28, 2023
Maintained: Buy
Price Target: $16 → $13
Current: $2.37
Upside: n/a
Mar 9, 2023
Downgraded: Hold
Price Target: $11 → $8
Current: $3.55
Upside: n/a
Mar 7, 2023
Upgraded: Hold
Price Target: $6 → $7
Current: $3.15
Upside: n/a
Feb 28, 2023
Maintained: Buy
Price Target: $51 → $55
Current: $26.82
Upside: n/a
Feb 24, 2023
Reiterated: Buy
Price Target: $57 → $46
Current: $96.72
Upside: n/a
May 11, 2022
Maintained: Sell
Price Target: $3.5
Current: $0.947
Upside: n/a
Aug 4, 2020
Maintained: Buy
Price Target: $23 → $24
Current: $91.23
Upside: n/a
Jul 30, 2020
Maintained: Hold
Price Target: $22 → $26
Current: $88.12
Upside: n/a
Jul 27, 2020
Maintained: Buy
Price Target: $18
Current: $15.39
Upside: n/a
Jul 22, 2020
Rated: Hold
Price Target: $90 → $95
Current: $83.65
Upside: n/a
Jul 8, 2020
Maintained: Hold
Price Target: $328
Current: $975.69
Upside: n/a
Jun 18, 2020
Maintained: Hold
Price Target: $35
Current: $64.12
Upside: n/a
Jun 10, 2020
Rated: Buy
Price Target: $125 → $116
Current: $201.97
Upside: n/a
Jun 3, 2020
Maintained: Hold
Price Target: €22.00 → €24.00
Current: $36.26
Upside: n/a
May 28, 2020
Rated: Buy
Price Target: $98 → $107
Current: $114.89
Upside: n/a
May 22, 2020
Maintained: Hold
Price Target: $154 → $178
Current: $114.34
Upside: n/a
May 21, 2020
Rated: Buy
Price Target: $31 → $38
Current: $90.93
Upside: n/a
May 5, 2020
Rated: Buy
Price Target: $67 → $63
Current: $79.64
Upside: n/a
May 4, 2020
Maintained: Buy
Price Target: $39
Current: $104.06
Upside: n/a
Mar 6, 2020
Downgraded: Hold
Price Target: n/a
Current: $19.06
Upside: n/a
Mar 6, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $41.91
Upside: n/a